Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
Cash Equivalents Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Equivalents
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
Verona Pharma PLC
NASDAQ:VRNA
Cash Equivalents
$336m
CAGR 3-Years
26%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Cash Equivalents
$302m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
39%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hikma Pharmaceuticals PLC's Cash Equivalents?
Cash Equivalents
0 USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Cash Equivalents amounts to 0 USD.

Back to Top